Medigen, INC. (ambis # 1808132) for laboratory & testing services

Ended Purchase Order Awarded Last action

Contract number
HHSN272201601338P
Awardee
Awarding agency
Obligated
$815,000

Award facts

Opportunity
Contract value 100% obligated
$815,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21701, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 -$800,000
Original award $1,615,000

About this award

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Medigen, Inc., a biotechnology company specializing in vaccine development. The $815,000.00 contract is for laboratory and testing services. Medigen has previously received grants from NIAID totaling over $4 million to support R&D on novel live-attenuated vaccines. This contract does not have a set-aside designation. The services are being provided directly to NIAID as the prime federal agency.

Quick answers

Who was awarded contract HHSN272201601338P?

HHSN272201601338P was awarded to Medigen, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 15, 2016.

How much is contract HHSN272201601338P worth?

The government has obligated $815,000 on HHSN272201601338P.

Was contract HHSN272201601338P competed?

The extent of competition for HHSN272201601338P was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award